Where does Anacor Pharmaceuticals, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Anacor Pharmaceuticals, LLC ranks #7,974 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Anacor Pharmaceuticals, LLC hold?

Anacor Pharmaceuticals, LLC holds 40 US utility patents granted between 2015 and 2023, spanning 7 technology areas.

What is Anacor Pharmaceuticals, LLC's Innovation Score?

Anacor Pharmaceuticals, LLC has an Innovation Score of 35.4 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Anacor Pharmaceuticals, LLC's patent grant rate increasing or decreasing?

Anacor Pharmaceuticals, LLC's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Anacor Pharmaceuticals, LLC's patents?

Anacor Pharmaceuticals, LLC's patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Anacor Pharmaceuticals, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Anacor Pharmaceuticals, LLC

Q: What technology areas does Anacor Pharmaceuticals, LLC focus on?

Anacor Pharmaceuticals, LLC's top technology area is C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium) with 39 patents, ranking #29 of 1,317 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 40 granted patents across 7 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Anacor ranks #7,974 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 7 technology areas.

#7,974
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.4/100): 17.8
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7974 · US Corporation #7,974 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 40 grants
UPPER-Q #7,974/49,997
PHOTO-FINISH ActiveVideo Networks
CPC-NARROW C07F · 7 areas
INNOV-THIN 35.4/100
CLAIMS-RICH 17.8 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ActiveVideo Networks, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Anacor’s 35.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (36%) Velocity 2.6 pts (7%) Breadth 9.4 pts (27%) Claim depth 10.6 pts (30%)

Qualcomm Incorporated · highest

85
Anacor Pharmaceuticals · this assignee

35
Hitachi Information… · near

35
Natco Pharma · near

35
Plasma-Therm · near

35
Quotient Technology · near

35
3D Lighting… · lowest

7

What this shows Anacor's Innovation Score is 35.4/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Anacor?

Each dot is one of Anacor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Anacor’s own 17.8 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Anacor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Anacor's grants concentrate

Anacor Pharmaceuticals, LLC is a focused PatentsView assignee: 7 CPC subclasses with 97.5% of grants classified under C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium). Peak complete grant year is 2017 (10 grants) versus a trough of 1 in 2018. By volume, Anacor sits between Automated Assembly Corporation and Bial-portela & CA, S.A..

Anacor's three-year grant acceleration

Anacor Pharmaceuticals, LLC shows 5 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Automated Assembly

40
Azurity Pharmaceu…

40
Activevideo Netwo…

40
Advanced Architec…

40
Art Design Works

40
Basf Enzymes

40
Bbpos

40
Bial-portela & CA

40
Anacor Pharmaceut… ◀

40

What this shows Anacor holds 40 patents at rank #7,979, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Anacor

By rank, the assignees closest to #7,979 in granted patent volume.

Leaders in C07F (Acyclic)

Other assignees with the most granted patents in Anacor's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Anacor, neither rank-band nor same-CPC leaders (those blocks stay above). In C07F (Acyclic), Anacor ranks #29 of 1,317 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Hitachi Information AND Telecommunication Engineering, Ltd. 35 Quotient Technology Inc. 35 Natco Pharma Limited 35 Plasma-Therm LLC 35

Anacor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Anacor Pharmaceuticals, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	10.0%
2016	7	17.5%
2017	10	25.0%
2018	1	2.5%
2019	3	7.5%
2020	6	15.0%
2021	4	10.0%
2022	2	5.0%
2023	3	7.5%

Which technologies does Anacor Pharmaceuticals, LLC patent most?

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 39

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 31

Y02A - Technologies FOR Adaptation TO Climate Change 20

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 5

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 4

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Anacor Pharmaceuticals, LLC's patent record in context - here's where to go next.

Anacor Pharmaceuticals, LLC's lead technology class is C07F (Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium), 97.5% of its portfolio - see every assignee active in that class. Explore C07F
Ranked #7,974 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Anacor Pharmaceuticals, LLC against Automated Assembly Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.